• The Indispensable Role of Pharmacists in T2D Care
    Nov 16 2023

    Join episode host, Todd Eury, founder and CEO of the Pharmacy Podcast Network, as he discusses the indispensable role of pharmacists in T2D care with Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP and Rohit Moghe, PharmD, MSPH, CDCES. These pharmacist experts will share insights on why the role of pharmacists is so important in T2D care, including reviewing data on how pharmacist involvement improves measurable outcomes for patients with T2D. To raise awareness, they will also review T2D treatment recommendations from major medical societies.

    This program is intended for clinicians. The information presented is aligned with the views and opinions of the speakers and is sponsored by Novo Nordisk. This podcast is not to be used as medical advice and is intended for educational purposes only.

    Faculty Presenters:

    Todd Eury, BS
    CEO
    Pharmacy Podcast Network Brownsville, Pennsylvania

    Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP
    Endocrine Clinical Pharmacist and Director of Education and Training in Diabetes Technology
    The Cleveland Clinic Cleveland, Ohio

    Rohit Moghe, PharmD, MSPH, CDCES
    Ambulatory Care & Population Health Clinical Pharmacist
    Trinity Health Mid-Atlantic Langhorne, Pennsylvania

    Show More Show Less
    17 mins
  • Should We Be Thinking Differently About Type 2 Diabetes?
    Jan 31 2022

    Should we be thinking differently about type 2 diabetes (T2D)? Join experts in T2D: Dr John Anderson (primary care provider), Ms Lucia Novak (Nurse Practitioner), and Dr Joshua Stolker (cardiologist) as they talk about ways to think differently about type 2 diabetes and consider factors in addition to A1C such as comorbidities, recommendations on managing patients with T2D from national endocrinology and cardiology societies, and how the cardiology community can work with the diabetology community to provide the best care for patients with T2D.

    This podcast is sponsored by Novo Nordisk and is intended for clinicians.

    Faculty Presenters:

    John E. Anderson, MD
    Internal Medicine and Diabetes
    The Frist Clinic
    Nashville, Tennessee

    Lucia M. Novak, MSN, ANP-BC, BC-ADM
    President and Owner
    Diabetes Consulting Services
    North Bethesda, Maryland
    Co-Executive Director
    Capital Health & Metabolic Center of Capital Diabetes & Endocrine Associates
    Camp Springs and Silver Spring, Maryland

    Joshua M. Stolker, MD
    STEMI Director
    Mercy Heart and Vascular
    Washington, Missouri
    Adjunct Associate Professor
    Saint Louis University
    St. Louis, Missouri

    Show More Show Less
    23 mins
  • The Increased Risk of Cardiovascular Disease in Patients With T2D
    Jan 17 2022

    What are the prevalence, increased risk, and impact of cardiovascular disease (CVD) among patients with type 2 diabetes (T2D)? Join experts: Dr John Anderson (primary care physician), Dr Pam Taub (cardiologist), and Dr Mark Greathouse (cardiologist) as they review the relationship between T2D and CVD, including how T2D exacerbates CVD and the risk from CVD, and what the national medical associations recommend for patients with T2D and CVD.

    This podcast is sponsored by Novo Nordisk and is intended for clinicians.

    Faculty Presenters:

    John E. Anderson, MD
    Internal Medicine and Diabetes
    The Frist Clinic
    Nashville, Tennessee

    Pam Taub, MD, FACC
    Cardiologist and Professor of Medicine
    Director, Cardiac Rehabilitation and Wellness Center
    UC San Diego Health
    San Diego, California

    Mark Greathouse, MD
    Senior Clinical Cardiologist
    St. Clair Health
    Pittsburg, Pennsylvania

    Show More Show Less
    16 mins
  • Understanding Insufficient GLP-1 Activity in T2D
    Jan 3 2022

    What is the impact of insufficient GLP-1 activity in type 2 diabetes (T2D)? Join experts in T2D: Dr John Anderson, Dr Javier Morales, and Dr Richard Pratley as they review the role of GLP-1 in glucose regulation, consider the impact of insufficient GLP-1 activity on pancreatic beta cells in patients with T2D, and discuss possibilities to overcome insufficient GLP-1 activity in patients with T2D.

    This podcast is sponsored by Novo Nordisk and is intended for clinicians.

    Faculty Presenters:

    John E. Anderson, MD
    Internal Medicine and Diabetes
    The Frist Clinic
    Nashville, Tennessee

    Javier Morales, MD, FACP, FACE
    Internal Medicine, Diabetes, and Primary Care
    Associate Clinical Professor
    Hofstra/Northwell School of Medicine at the Donald and Barbara Zucker School of Medicine
    Long Island, New York

    Richard E. Pratley, MD
    Internal Medicine and Diabetes
    AdventHealth Diabetes Institute
    Orlando, Florida

    Show More Show Less
    9 mins
  • The Role of Endogenous GLP-1
    Dec 13 2021

    What is the role of endogenous GLP-1 in the pathophysiology of T2D? Join multidisciplinary experts in T2D: Dr John Anderson, Dr Vivian Fonseca, and Dr Jim Gavin as they discuss the fascinating history of GLP-1 discovery and the role of endogenous GLP-1 in the pathophysiology of T2D.

    This podcast is sponsored by Novo Nordisk and is intended for Healthcare Practitioners.

    Faculty Presenters:

    John E. Anderson, MD
    Internal Medicine and Diabetes
    The Frist Clinic
    Nashville, Tennessee

    James R. Gavin III, MD, PhD
    Clinical Professor of Medicine, Emory University
    Chief Medical Officer, Healing Our Village, Inc.
    Atlanta, Georgia

    Vivian A. Fonseca, MD, FRCP
    Professor of Medicine, Assistant Dean for Research
    Tulane University
    New Orleans, Louisiana

    Show More Show Less
    16 mins
  • Beta-Cell Dysfunction: A Driver of T2D?
    Nov 29 2021

    What do you know about the role of beta-cell dysfunction in the pathophysiology of type 2 diabetes (T2D)? Join primary care experts in T2D: Dr. John Anderson, Dr. Stephen Brunton and Dr. James LaSalle as we discuss the beta-cell function and its critical role in T2D pathogenesis, what clinicians know or should know about it and how it is measured in the clinic, and how our current knowledge of beta-cell function in T2D may affect future research on T2D treatment.

    This podcast is sponsored by Novo Nordisk and is intended for clinicians. The opinions expressed are those of the speakers and not Novo Nordisk.

    Faculty Presenters:

    John E. Anderson, MD
    Internal Medicine and Diabetes
    The Frist Clinic
    Nashville, Tennessee

    Stephen Brunton, MD, FAAFP
    Executive Director
    Primary Care Metabolic Group
    Winnsboro, South Carolina

    James LaSalle, DO, FAAFP
    Medical Arts of Excelsior Springs, Inc.
    Excelsior Springs, Missouri

    Show More Show Less
    11 mins
  • Act Early to Lighten the Heavy Burden of T2D
    Nov 15 2021

    What is the burden of the type 2 diabetes (T2D) epidemic? Join experts in T2D: Dr. John Anderson (primary care provider), Dr. Susan Cornell (clinical pharmacist and certified diabetes care and education specialist) and Dr. Doron Schneider (primary care provider) as they discuss the enormous physical, emotional, psychological and economic burden of T2D and its comorbidities on the US healthcare system and on their patients and what they, as clinicians need to do to ease this burden.

    This podcast is sponsored by Novo Nordisk and is intended for clinicians.

    Faculty Presenters:

    John E. Anderson, MD
    Internal Medicine and Diabetes
    The Frist Clinic
    Nashville, Tennessee

    Susan Cornell, BS, PharmD, CDCES, FAPhA, FADCES
    Associate Director of Experiential Education
    Professor of Pharmacy Practice
    Midwestern University Chicago College of Pharmacy
    Downers Grove, Illinois

    Doron Schneider, MD, MBA, FACP
    Vice President, Population Health Services
    Tandigm Health
    West Conshohocken, Pennsylvania

    Show More Show Less
    19 mins